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Summary
Objective: Mutations in the GJB2 gene are a major cause of autosomal recessive and
sporadic non-syndromic hearing loss in many populations. A single mutation of this
gene (35delG) accounts for approximately 70% of mutations in Caucasians with a
carrier frequency of 2—4% in Europe. This study aims to determine the rate of 35delG
carrier frequency in Iran.
Methods: Genomic DNA was extracted from a total of 550 unaffected unrelated
subjects from 4 provinces of Iran following the standard phenol chloroform procedure.
The one base pair deletion (35delG) was analysed using a nested PCR procedure;
35delG mutation carriers were subsequently confirmed by sequence analysis. More-
over, using the Binomial probability distribution, we compared the 35delG carrier
frequency of Iranian population with the various Middle Eastern and overall European
populations.
Results: Of the four populations studied, we found a high carrier frequency of 2.8% in
Gilan province in the north of Iran. The overall 35delG carrier frequency was found to* Corresponding author. Tel.: +98 381 3346692; fax: +98 381 3330709.
E-mail address: mchalesh@yahoo.com (M.H. Chaleshtori).
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be 1.25% in the populations studied (our present and previous data) which is similar to
the overall 35delG carrier frequency detected in Middle Eastern populations, but
Significantly lower than that identified in European populations.
# 2007 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Genetic deafness is a very common disorder which
occurs in approximately 1/2000 live births [1].
Genetic deafness is highly heterogeneous and more
than 100 genes are predicted to cause this disorder
in humans [2]. In spite of this large genetic hetero-
geneity, mutations in the GJB2 gene alone, encoding
connexin 26, are responsible for approximately half
of the severe to profound autosomal recessive non-
syndromic deafness in many populations [1,3]. A
single mutation of this gene, namely 35delG, is of
great importance due to its high pathogenicity and
frequency. 35delG homozygosity is associated with
more severe deafness compared with other homo-
zygote or compound heterozygote GJB2 mutations
[4,5]. Moreover, 35delG accounts for about 70% of
the GJB2 mutations in Caucasians with a carrier
frequency of 2—4% in Europe [3,6,7]. Conversely
it is less frequent or even absent in other ethnic
groups where other common mutations prevail such
as 235delC which displays a carrier frequency of 1—
2% in the Japanese population [8,9], 167delT in the
Ashkenazi Jews population with carrier frequency of
4.03% [10] and V37I in Taiwan with carrier frequency
of 8.5% [11]. The previous studies revealed a specific
combination of GJB2 mutations types and frequen-
cies in different populations of Iran [12—15]. In the
present study, we have investigated the carrierFig. 1 35delG heterozygotes were collected from four provi
frequency (2.8%), while the pale shades representing the lowfrequency of 35delG mutations among 550 unaf-
fected unrelated subjects from four provinces of
Iran.2. Materials and methods
In total, 550 unaffected unrelated subjects with
different ethnic origin (Gilak, Azeri, Persian and
Lur) from four provinces of Iran including Gilan in
north, Azarbaijan Sharqi in north west, Hamadan in
west and Chaharmahal va Bakhtiari in south west,
were studied (Fig. 1). Informed consent was
obtained from all subjects. Genomic DNA was
extracted from 0.5 ml peripheral blood following
the standard phenol chloroform procedure. The
35delG one base pair deletion was assayed using a
nested PCR procedure. The entire coding sequence
of GJB2 gene was amplified using primers CX124F 50
CTC CCT GTT CTG TCC TAG CT 30/CX929R 50 CTC ATC
CCT CTC ATG CTG TC 30 (806 bp) at an annealing
temperature of 60 8C. The amplified product was
then diluted and used as a template for a second
round of PCR using primers CX210F 50CAC GCT GCA
GAC GAT CC30/CX252R 50GGT GGA GTG TTT GTT
CAC30 (43 bp) at an annealing temperature of
56 8C. The amplified products were then separated
by electrophoresis on a 15% Polyacrylamide gel (40%
19:1 Acrylamide: Bisacrylamide) at 35 mA for 2.5 hnces of Iran. A dark shade corresponds to a higher carrier
er frequency (1%).
High carrier frequency of the GJB2 mutation (35delG) in the north of Iran 865and the products were then visualised by silver
staining. The 35delG heterozygotes were detected
as two separate bands of 43 bp for the wild type and
42 bp for the mutant allele and confirmed by direct
sequencing of the amplified products (806 bp).
Sequencing was performed using BigDye terminator
V3.1 cycle sequencing kit (Applied Biosystems) on an
ABI 3100 DNA sequencer (Applied Biosystems).
The carrier rate of the 35delG in Iranian popula-
tion was compared with that of the various Middle
Eastern and overall European populations using the
95% confidence interval of carrier rate based on
Binomial probability distribution [16].Fig. 2 Electropherograms and polyacrilamide gel elec-
trophoresis of wild type and mutant allele of 35delG. (a)
Nucleotide sequences of wild type and (b) heterozygous
(carrier) 35delG identified in this study. (c) Nested PCR
analysis of the 35delG mutation; lane 1: negative control,
lanes 2, 3, 4, 6, 9: wild type, lanes 5, 8: 35delG hetero-
zygous, lane 7: positive control (35delG homozygous).3. Results
Ten of 550 subjects (1.8%) were found to be carriers
of the 35delG mutation (95% Binomial confidence
interval (CI), 0.88—3.32%). Table 1 shows carrier
frequencies of the 35delG mutation by province.
A rate of 1% carrier frequency was detected in
Azarbaijan Sharqi, Hamadan and Chaharmahal va
Bakhtiari in north west, west and south west of the
country. The highest 35delG carrier frequency
(2.8%) was detected in Gilan province in north of
Iran. 35delG electropherograms and polyacrilamide
gel electrophoresis of wild type and mutant allele
are shown in Fig. 2.
The 35delG carrier frequency found in this study
(1.8%) is statistically similar to that of the other
Middle Eastern populations. However, the overall
35delG carrier rate of 1.30% (95% Binomial CI, 0.96—
1.72%) detected in Middle Eastern populations is
significantly lower than that: 2.69% (95% Binomial
CI, 2.18—3.27%) identified in European populations
(Table 2).4. Discussion
The 35delG mutation is responsible for 10% of all
childhood hearing loss and for 20% of all childhood
hereditary hearing loss in American Caucasians with
northern and southern European origin [17]. More-
over, 35delG accounts for about 70% of the GJB2Table 1 Carrier frequency of the 35delG mutation in the
Province Subjects
Gilan 250
Azarbaijan Sharqi 100
Hamadan 100
Chaharmahal va Bakhtiari 100
Total 550mutations in Caucasians with a carrier frequency of
2—4% in Europe [3,6,7]. The 35delG mutation is of
great importance concerning its high pathogenicity,
severity of disease and frequency [4,5].
In the present study, the carrier frequency of
35delG mutations among 550 unaffected unrelated
Iranian subjects from four provinces ranged from 1%
in Azarbaijan Sharqi (north west), Hamadan (west),
and Chaharmahal va Bakhtiari (south west) to 2.8%
in Gilan (north) with an average carrier frequency of
1.8%. The high rate of 35delG carrier frequency in
Gilan is consistent with the previous finding of high
35delG mutation frequency (34 and 27% of all deaf-various provinces investigated
Carriers Carrier frequency (%)
7 2.8
1 1
1 1
1 1
10 1.8
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Table 2 GJB2 35delG mutation carrier frequencies, observed rates and 95% confidence intervals (Binomial) in 12
Middle Eastern populations compared with an overall 13 European populations (24)
Population Rate of 35delG
heterozygote
Carrier observed
rate (%)
95% CI Binomial
distribution
Reference
Cyprus (Greek Cypriots) 10/405 2.47 1.19—4.50 [24]
Lebanon 7/300 2.33 0.94—4.75 [26]
Israel (Ashkenazi Jewish) 1/467 0.21 0.01—1.19 [27]
Persian Jews 2/59 3.39 0.41—11.71 [25]
Iraqi Jews 1/115 0.87 0.02—4.75 [25]
Egypt 0/95 0 0—5.67 [25]
Oman 0/280 0 0—1.31 [19]
Turkey 12/674 1.78 0.92—3.09 [22]
Turkey 5/429 1.17 0.38—2.70 [23]
Azerbaijan 0/75 0 0—4.8 [21]
Iran 0/250 0 0—1.47 [18]
Iran 10/550 1.8 0.88—3.32 Present study
Middle East (overall) 48/3699 1.30 0.96—1.72 Present study
Europe (overall) 97/3610 2.69 2.18—3.27 [24]ness chromosomes investigated) amongst deaf
families in north of the country [13,15]. The enrich-
ment of the 35delG mutation in both deaf and
normal populations of Gilan is likely to reflect a
founder effect within this region perhaps relating
to the geographical isolation of this population. Our
previous study of 890 families with autosomal reces-
sive or sporadic hearing loss revealed that 35delG is
the most prevalent GJB2 mutation accounting for
74.5% of the GJB2 mutations chromosomes account-
ing for 10.8% of all chromosomes studied in Iran [15].
A lower rate of 35delG carrier frequency was
found in the other populations studied and in total
a carrier frequency of 1.8% was identified in the four
populations studied. This is a higher rate than our
studies of Tehran, which represent a very mixed
population, in which we were unable to detect
the mutation in a control group of 250 blood donors
[18]. Taken together our data indicates a lower rate
of 35delG mutation in the south and south east
compared with north and north west of the country
amongst deafness families [13,15], and an overall
35delG carrier frequency in the general population
in Iran is estimated to be less than 1.25%. This
corresponds to a slightly lower rate of 35delG carrier
frequency compared with that of our neighbouring
country Turkey (Table 2). A low frequency or
absence of 35delG carriers have been reported in
other our neighbouring countries including Oman,
Pakistan and Azerbaijan [19—23]. This is consistent
with a decreasing GJB2 mutation frequency in a
north westerly to south easterly gradient across Iran
[13,15]. Using the Binomial probability distribution,
we analyzed 35delG carrier rate of Iranian popula-
tion compared with those of European and Middle
Eastern populations. Our results are in agreement
with the previous meta-analysis studies [7,24].In conclusion, the overall 35delG carrier rate of
1.25% found in Iranian population represented a
similar rate of that detected in Middle Eastern
populations, but significantly lower than that iden-
tified in European populations. The high carrier
frequency of 35delG mutation in Gilan in north of
the country is likely to reflect a founder effect,
carrier advantage or both. As 35delG accounts for
71.6% of the GJB2 mutations in overall Iranian
population, our simple 35delG screening test would
facilitate diagnosis of congenital deafness and early
treatment of the affected subjects particularly in
regions with high carrier frequency like Gilan
[15,25].Acknowledgement
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